Stopped: On May 13, 2024, the FDA released a communication that Cue Health tests should no longer be used.
The investigators will examine whether a combination of at-home nucleic acid amplification tests, on-demand telemedicine, and delivery of prescriptions such as Paxlovid quickly after testing positive for COVID-19, can reduce severe outcomes and hospitalization of immunocompromised patients and those who are 65 years and older. They will also analyze whether these efforts lower the cost of care compared to standard of care.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Number of Participants With Hospitalizations Including COVID Medications
Timeframe: During study participation (on average 12 months)
Cost of Care
Timeframe: During study participation (on average 12 months)